Tandem Diabetes Care Inc
(STU:TD5A)
€
29.15
-1.65 (-5.36%)
Market Cap: 1.92 Bil
Enterprise Value: 1.92 Bil
PE Ratio: 0
PB Ratio: 8.66
GF Score: 82/100 
Tandem Diabetes Care Inc at Wells Fargo Virtual Healthcare Conference Transcript
Sep 09, 2020 / 04:00PM GMT
Release Date Price:
€91.88
(+0.76%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good afternoon and good morning. I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo. Welcome to our 2020 Virtual Health Care Conference. With us, we have the management team from Tandem Diabetes, John Sheridan, the CEO; and Leigh Vosseller, the CFO. The format is going to be fireside chat for 30 minutes. We're going to try to get one audience poll question in here. So John and Leigh, thanks so much for joining us.
John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director
Thanks for having us, Larry.
Leigh A. Vosseller
Tandem Diabetes Care, Inc. - Executive VP, CFO & Treasurer
Thank you.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Great. So I wanted to start at a high level. First, with the strategy. And
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers